Literature DB >> 897680

Bifunctional intercalators: relationship of antitumor activity of diacridines to the cell membrane.

R M Fico, T K Chen, E S Canellakis.   

Abstract

The in vivo antitumor effectiveness [as measured by the percentage increase in life-span (ILS%)] of 28 diacridine bis-intercalators of nucleic acids shows a highly significant correlation with their effect on phenomena associated with plasma membrane as well as a high degree of structural specificity. In contrast, the ILS% does not correlate with the uptake of these diacridines by cells, nor with the inhibition of RNA synthesis or of DNA synthesis or with the inhibition of growth of cells in culture. The possibility that the antitumor effectiveness of actinomycin D, another DNA intercalator, is associated with sites of action other than the hibition of RNA synthesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 897680     DOI: 10.1126/science.897680

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Computer-aided molecular modeling and design of DNA-inserting molecules.

Authors:  F J van der Klein-de Gunst; J H van Boom; R M Liskamp
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

2.  Cardiotoxic effects of anthracyclines.

Authors:  M R Bristow
Journal:  West J Med       Date:  1983-09

3.  Novel acriflavin resistance genes, acrC and acrD, in Escherichia coli K-12.

Authors:  H Nakamura
Journal:  J Bacteriol       Date:  1979-07       Impact factor: 3.490

4.  Induction of murine erythroleukemia differentiation by actinomycin D.

Authors:  M Terada; E Epner; U Nudel; J Salmon; E Fibach; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

5.  Cell differentiation and flagellar elongation in Naegleria gruberi. Dependence on transcription and translation.

Authors:  C Fulton; C Walsh
Journal:  J Cell Biol       Date:  1980-05       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.